American Heart Journal
Volume 151, Issue 5 , Pages 976.e1-976.e6 , May 2006

Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: Analysis of the Orbofiban in Patients with Unstable coronary Syndromes–Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial

  • Shaul Atar, MD

      Affiliations

    • Division of Cardiology, University of Texas Medical Branch, Galveston, TX
    • ,
  • Christopher P. Cannon, MD, FACC

      Affiliations

    • Division of Cardiology, Brigham and Women's Hospital, Boston, MA
    • ,
  • Sabina A. Murphy, MPH

      Affiliations

    • Division of Cardiology, Brigham and Women's Hospital, Boston, MA
    • ,
  • Salvatore Rosanio, MD,PhD

      Affiliations

    • Division of Cardiology, University of Texas Medical Branch, Galveston, TX
    • ,
  • Barry F. Uretsky, MD, FACC

      Affiliations

    • Division of Cardiology, University of Texas Medical Branch, Galveston, TX
    • ,
  • Yochai Birnbaum, MD, FACC

      Affiliations

    • Division of Cardiology, University of Texas Medical Branch, Galveston, TX
    • Corresponding Author InformationReprints requests: Yochai Birnbaum, MD, The Division of Cardiology, The University of Texas Medical Branch, 5.106 John Sealy Annex, 301 University Blvd., Galveston, TX 77555-0553.

Received 27 September 2005 ,Accepted 7 February 2006.

  • Image Result

    The effect of statin use on the overall incidence of GI bleeding (presented as percentage) in patients on orbofiban or placebo.

    The effect of statin use on the overall incidence of GI bleeding (presented as percentage) in patients on orbofiban or placebo.

  • Image Result

    The effect of statins use on the overall incidence of severe and major GI bleeding (presented as percentage) in patients on orbofiban or placebo.

    The effect of statins use on the overall incidence of severe and major GI bleeding (presented as percentage) in patients on orbofiban or placebo.

  • Image Result

    The effect of statin use on the incidence of any post-discharge GI bleeding (presented as percentage) in patients on orbofiban or placebo.

    The effect of statin use on the incidence of any post-discharge GI bleeding (presented as percentage) in patients on orbofiban or placebo.

  • Image Result

    The effect of prior lipid-lowering medication use on the incidence of inhospital GI bleeding (presented as percentage) in patients on orbofiban or placebo.

    The effect of prior lipid-lowering medication use on the incidence of inhospital GI bleeding (presented as percentage) in patients on orbofiban or placebo.

PII: S0002-8703(06)00128-1

doi: 10.1016/j.ahj.2006.02.013

American Heart Journal
Volume 151, Issue 5 , Pages 976.e1-976.e6 , May 2006

Article Tools

* Image Usage & Resolution